Stiripentol（STP）是一种抗惊厥剂,能通过抑制CYP3A4和CYP2C19介导的氯巴占（CLB）N-去甲基化过程,减少其代谢为N-去甲基氯巴占（NCLB)。其中,对CYP3A4为非竞争性抑制,对CYP2C19为竞争性抑制。

-25~-15℃保存，有效期3年

[1] Giraud C, Treluyer JM, Rey E, Chiron C, Vincent J, Pons G, Tran A. In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism. Drug Metab Dispos. 2006 Apr,34(4):608-11. doi: 10.1124/dmd.105.007237. Epub 2006 Jan 13. PMID: 16415114.[2]Cao D, Ohtani H, Ogiwara I, Ohtani S, Takahashi Y, Yamakawa K, Inoue Y. Efficacy of stiripentol in hyperthermia-induced seizures in a mouse model of Dravet syndrome. Epilepsia. 2012 Jul,53(7):1140-5. doi: 10.1111/j.1528-1167.2012.03497.x. Epub 2012 May 11. PMID: 22578034.